Overview

* Quaker Chemical ( KWR ) Q3 sales rose 7% yr/yr, beating analyst expectations

* Adjusted EPS for Q3 beat consensus, reflecting strong operational execution

* Adjusted EBITDA for Q3 exceeded analyst estimates, driven by sales growth

Outlook

* Company anticipates soft market conditions to persist through year-end

* Quaker Chemical ( KWR ) expects year-over-year revenue and earnings growth in Q4

* Company aims to sustain above-market growth in 2026 and beyond

Result Drivers

* NEW BUSINESS WINS - Co attributes 5% of organic sales growth to new business wins globally, offsetting soft end market conditions

* ASIA/PACIFIC GROWTH - Asia/Pacific segment net sales increased 18% Y/Y, driven by organic sales, acquisitions, and favorable currency impacts

* ACQUISITIONS - 5% sales growth contribution from acquisitions, aiding overall revenue increase

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $493.84 $475.05

mln mln (4

Analysts

)

Q3 Beat $2.08 $2.01 (5

Adjusted Analysts

EPS )

Q3 Miss $36.27 $36.60

Adjusted mln mln (3

Net Analysts

Income )

Q3 Net $30.5

Income mln

Q3 Beat $82.85 $81.26

Adjusted mln mln (5

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the commodity chemicals peer group is "buy"

* Wall Street's median 12-month price target for Quaker Chemical Corp ( KWR ) is $160.00, about 18.5% above its October 29 closing price of $130.47

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)